Latest News
- Determining how nucleoside metabolism regulates contrasting immune functions in the rare disease PNP deficiency
Findings from a new UCLA study reveal previously unknown functional links between STING signaling and immunometabolism, and also suggests that PET imaging could provide a widely accessible approach to measure the effects of STING-activating drugs.
August 15, 2022 6:00 AM
detail - PET scan visualization can measure effects of STING-activating drugs and could help guide clinical development of this potential anti-tumor therapy
Findings from a new UCLA study reveal previously unknown functional links between STING signaling and immunometabolism, and also suggests that PET imaging could provide a widely accessible approach to measure the effects of STING-activating drugs.
August 12, 2022 9:00 AM
detail - Improve lung cancer outcomes with low-dose CT screening
While not all lung cancers are caused by cigarette smoking, quitting the habit—or never starting—is an important part of cancer prevention. For high-risk current and former smokers, lung cancer screening and early detection can significantly improve outcomes.
August 09, 2022 9:00 AM
detail - UCLA researchers awarded Department of Defense funding to improve prostate cancer treatment outcomes
A UCLA team led by Dr. Paul Boutros has been awarded over $2.7 million in research funding from the U.S. Department of Defense to support two projects that will use computational models and DNA sequencing to improve prostate cancer treatment outcomes.
July 22, 2022 11:00 AM
detail - Cancer genetic counseling comes into its own at UCLA
About ten percent of cancers are caused by inherited mutations, and learning whether an individual has such mutations can help patients, families and health care providers make informed choices about managing a cancer diagnosis or elevated cancer risk.
July 21, 2022 6:00 AM
detail - RNA may be an informative biomarker for head and neck cancer treatment, UCLA study says
Liquid biopsies for certain cancers are gaining popularity because they’re less invasive than traditional ones. They can be used to monitor cancer treatment, providing physicians a way to reliably check to see whether that treatment is working.
July 15, 2022 6:00 AM
detail - NEJM editorial by UCLA’s Sara Hurvitz: DESTINY-Breast04 results are ‘practice-changing’
A Phase 3 trial showing positive results for a drug given to breast cancer patients who have low levels of the HER2 protein is “immediately practice-changing,” UCLA’s Sara A. Hurvitz, MD, writes in an editorial published in The New England Journal of Medicine.
July 07, 2022 6:00 AM
detail - UCLA Health earns Comprehensive Center of Excellence designation for radiopharmaceutical therapy as work continues on new facility
UCLA Health’s Ahmanson Translational Theranostics Division has been designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine & Molecular Imaging (SNMMI).
June 30, 2022 9:00 AM
detail - UCLA study identifies receptor that could alleviate need for chemo, radiation pre-T cell therapy
In this interview with the National Cancer Institute, Dr. Patricia Ganz discusses psychosocial distress in cancer survivors and the challenges and opportunities in this area.
June 08, 2022 9:00 AM
detail - Meeting cancer survivors' psychosocial health needs: a conversation with Dr. Patricia Ganz
In this interview with the National Cancer Institute, Dr. Patricia Ganz discusses psychosocial distress in cancer survivors and the challenges and opportunities in this area.
June 07, 2022 9:00 AM
detail - UCLA researchers presenting work at ASCO annual meeting
UCLA physicians and scientists are presenting data and research findings at the American Society of Clinical Oncology’s annual meeting in Chicago June 3-7, 2022.
June 03, 2022 9:00 AM
detail - UCLA study finds strategy to degrade a key cancer cell-surface protein to invigorate immune attack on tumors
A team of UCLA researchers led by Roger S. Lo, MD, PhD, has identified a method to degrade tumor cell-surface PD-L1, thereby making tumors susceptible to immune attack.
May 31, 2022 9:00 AM
detail - Jie Deng receives Young Investigator Award from ASCO’s Conquer Cancer
Jie Deng, MD, PhD, a resident in the Department of Radiation Oncology at UCLA Health and the UCLA Jonsson Comprehensive Cancer Center, is among the recipients of a Young Investigator Award given by Conquer Cancer, the ASCO Foundation.
May 25, 2022 8:00 AM
detail - Diversifying clinical trials, a key piece of health equity
For far too long, cancer researchers rarely questioned why clinical trials lacked diversity. Maria Garcia-Jimenez, MD, MHS, is committed to changing that and to reducing disparities across the cancer care continuum – from diagnosis and treatment to end of life care.
May 24, 2022 9:00 AM
detail - Tim Donahue to receive Serge & Yvette Dadone Clinical Teaching Award
Timothy R. Donahue, MD, will be honored with the Serge & Yvette Dadone Clinical Teaching Award when the UCLA David Geffen School of Medicine holds its annual Awards for Education Reception on June 7.
May 20, 2022 6:00 AM
detail